“Lane and President Trump have been familiar with both living in the Westchester area for many years, but there was no regular contact until this year when they discussed matters surrounding Covid on this occasion,” Regener said in a statement to CNN Business.
However, it has not yet been approved by the Food and Drug Administration. The FDA may approve its administration on an individual basis through so-called “compassionate use” requests. Regeneron confirmed to CNN Business that he made such a request to the FDA to allow Trump to operate the drug.
Schliefer defended Trump’s decision to give him a cocktail last week, telling CNN’s Wolf Blitzer that Trump “is in a high-risk group for a variety of reasons” and that “we hope we can boost his immune system enough. He can win this and achieve a full recovery.” Can. “
“We’ve got a lot of information, but we’re still in the experimental phase. But when you’re in the midst of an epidemic and you’re at risk, we think it’s worth trying.” .
Regeneron added in his statement to CNN Business that he was in discussions with the FDA “about the possibility of emergency use authorization for REGN-COV2” following the release of positive data about the drug last week.
Regeneron said it is also in the process of studying the effect of cocktails on hospitalized patients, as well as whether it can prevent infection in people exposed to Covid-19.
Julia Chatterley, president of CNN’s Julia Chatterley, president and chief scientific officer of Regeron, said in an interview on Monday that the company hopes to get patients a higher dose of REGN-COV2 in the next few months due to its partnership with Big Pharma giant Roche. .
“We are on track to deliver 1,000,000 doses by the end of the year and … produce 100,000 doses a month while demand may still exceed that,” Yankopouss said. “If the drug is really working and has the effects that we hope it will, it can do a lot of good for a lot of people.”
.
